COMPLEX BIOMARKER GROUP FOR DETECTING LUNG CANCER IN A SUBJECT LUNG CANCER DIAGNOSTIC KIT USING THE SAME METHOD FOR DETECTING LUNG CANCER USING INFORMATION ON COMPLEX BIOMARKER AND COMPUTING SYSTEM EXECUTING THE METHOD

摘要

The present invention relates to a composite biomarker group for diagnosing lung cancer in a testing subject, a kit for diagnosing lung cancer using the same, a method for using information of the composite biomarker group, and a computing system conducting the same. According to the present invention, the composite biomarker group for diagnosing lung cancer is composed of individual biomarker carcinoembryonic antigen (CEA), human epididymis protein 4 (HE4), apolipoprotein A-II (ApoA2), transthyretin (TTR), soluble vascular cell adhesion molecule-1 (sVCAM-1), and regulated on activation, normal T cell expressed and secreted (RANTES) chemokine (C-C motif) ligand 5.